The EPS estimate of UnitedHealth Group Incorporated (NYSE:UNH) for quarter ended 2016-12-31 is $2.07.
EPS projections 7 and 30 days ago were $2.07 and $2.07 respectively. Analysts projected $2.07 and $2.07 respectively as EPS 60 and 90 days ago. The projections shows a change of 0.02% from estimates of 7-days ago.
The EPS revisions up and down count in the preceding 7 days were 8 and 1 respectively. The count of bullish revisions in earnings in the last 1-month, 60, 90 and 120 days were 8, 8, 8 and 10.
The count of bearish revisions of EPS in the last 1-month, 60, 90 and 120 days were 1, 1, 1 and 1.
The count of EPS revisions bullish and bearish in the last 18 days were 9 and 1 respectively.
The EPS projection prior to the release of actual report for the period closed 2 is $2.07 on basis of 13 EPS estimates. As on 2016-07-19, the reported EPS was $1.96, showing a surprise of $0.07 or 3.7%. It showed a standard deviation of 0.03.
Quarterly Sales Estimates
The arithmetic mean of released annual sales estimates for UnitedHealth Group Incorporated (NYSE:UNH) is $49711.168 and the median is $49480.59. The estimate is calculated by 5 analysts for the fiscal 2017.
The highest annual estimate is $51186 and the lowest estimate is $48745. The standard deviation of given annual sales estimates is 993.017%.
As many as 5 and 5 analysts have increased and decreased sales estimate, respectively in last seven days. It shows a percentage change of -0.084% from the past week.
Almost 5 and 5 analysts have increased and decreased sales estimate, respectively in last one month. It shows a percentage change of -0.084% from last month.
The number of analysts who have upped and decreased their sales projections in the last one-quarter is 5 and 5 respectively. The change in the estimate from last quarter is -0.084%.
1 Chart Pattern Every Investor Should Know